Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 923 Lung Neoplasms 626 Small Cell Lung Carcinoma 172 Colorectal Neoplasms 136 Melanoma 110 Breast Neoplasms 108 Neoplasms 98 Ovarian Neoplasms 94 Neoplasm Metastasis 91 Pancreatic Neoplasms 77 Squamous Cell Carcinoma of Head and Neck 70 Stomach Neoplasms 60 Carcinoma, Renal Cell 58 Head and Neck Neoplasms 57 Triple Negative Breast Neoplasms 51 Esophageal Neoplasms 51 Endometrial Neoplasms 51 Prostatic Neoplasms 47 Uterine Cervical Neoplasms 44 Colonic Neoplasms 43 Urinary Bladder Neoplasms 41 Mesothelioma 41 Mesothelioma, Malignant 38 Carcinoma, Hepatocellular 38 Brain Neoplasms 34 Sarcoma 30 Carcinoma, Transitional Cell 29 Adenocarcinoma of Lung 29 Lung Diseases 26 Disease 26

Interventions

atezolizumab 1 alectinib 1 Vemurafenib 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Genomic Instability × Thoracic × 90 days × Clear all

NCT02314481 2026-05-04

DARWINII

University College, London

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Genomic Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡